Join UC Irvine Health for the 17th Annual Allen and Lee-Hwa Chao Lectureship in Cancer Research in Honor of H.H. Chao.
The free lecture, "Translating a Trillion Points of Data Into Therapies, Diagnostics and New Insights Into Disease," will be given by Dr. Atul Butte, the director for Computational Health Sciences and professor of pediatrics at UC San Francisco.
There is an urgent need to take what we have learned in our new “genome era” and use it to create a new system of precision medicine, delivering the best preventative or therapeutic intervention at the right time, for the right patients.
Butte's lab at UCSF builds and applies tools that convert trillions of points of molecular, clinical, and epidemiological data—measured by researchers and clinicians over the past decade and now commonly termed “big data”—into diagnostics, therapeutics, and new insights into disease.
Butte, a computer scientist and pediatrician, will highlight how publicly-available molecular measurements can be used to find new uses for drugs including drugs for inflammatory bowel disease and cancer, discovering new diagnostics include blood tests for complications during pregnancy, and how the next generation of biotech companies might even start in your garage.
Location: The Arnold & Mabel Beckman Center of the National Academies of Sciences & Engineering
Date: Feb. 23, 2016
Time: Reception begins at 5 p.m.; lecture starts at 6 p.m.
RSVP: RSVP no later than Feb. 12 by emailing ChaoLectureRSVP@uadv.uci.edu or by calling 714-456-5800.
Learn more ›
About Dr. Atul Butte, MD, PhD
Atul Butte, MD, PhD, is the inaugural director of the Institute of Computational Health Sciences at the University of California,
San Francisco and a professor of pediatrics. Butte is also the executive director for clinical informatics across the six University of California medical schools and medical centers.
He trained in computer science at Brown University, worked as a
software engineer at Apple and Microsoft, received his medical degree
at Brown University, trained in pediatrics and pediatric endocrinology
at Boston Children’s Hospital and received his PhD from Harvard Medical School and MIT.
Butte has authored nearly 200 publications, with research repeatedly featured in Wired, The New York Times and The Wall Street Journal. In 2013, he was recognized by the White House as an Open Science Champion
of Change for promoting science through publicly available data.
Butte is founder of three investor-backed data-driven companies: Personalis, Carmenta and NuMedii. He is also the principal investigator
of the California Initiative to Advance Precision Medicine and the principal investigator for ImmPort, the clinical and molecular data repository for
the National Institute of Allergy and Infectious Diseases.